Trial intelligence / Profile preview

CHF 1535 vs Beclomethasone Dipropionate in Uncontrolled Asthma

NCT01577082Phase 3Completed

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Apr 2012
Primary completion
Nov 2012
Modality
Orthosteric Ligands
Countries
9
01

Overview

A Phase 3 trial of beclometasone dipropionate + formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Apr 2012; status: completed.

02

Drugs

beclometasone dipropionate + formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01577082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01577082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call